![]() Usage of Nucleo CMP Forte in the combined treatment of patients has more expressed positive influence on problems with walking. Nucleo CMP Forte have been prescribed to patients with lumbosciatalgia, alcoholic and diabetic polyneuropathies or trigeminal neuralgia, although their mechanism of action remains to be established, Little is known about the beneficial effects of nucleotides on the central nervous system. En caso de sobredosis o ingestión accidental, consultar al Servicio de Información. ![]() Forma de administración del inyectable: introducir la. Niños: 2 cápsulas al día, según criterio médico. Niños: 1 inyección intramuscular cada 2 o 3 días, según criterio médico. SOBREDOSIS Dada la escasa toxicidad del preparado no se prevé la intoxicación ni aún la accidental. Adultos: 1 inyección intramuscular cada 24 horas o en días alternos. We used non-parametric test χ 2 to evaluate efficacy of therapy. Núcleo CMP Forte cápsulas se administra por vía oral. Patients filled questionnaire of life quality EQ-5D-3L (Ukraine 2004, EuroQol) on the first and tenth day of treatment. They were compared into two groups: A 30 patients received standard treatment, B 29 diabetics additionally were taken Nucleo CMP Forte (1 capsule three times a day). Methods: It was examined 59 (41≧9 years old) patients with type 2 DM and DPNP. The aim: To evaluate the efficacy of Nucleo CMP Forte (Cytidine 5- disodium monophosphate and Uridine 5- trisodium triphosphate) in the combined treatment of patients with DPNP. New medications in DPNP have to be studied. Introduction: The protocols of medical care of diabetic peripheral neuropathy (DPNP) are developed but positive effect cannot be achieved in all patients.
0 Comments
Leave a Reply. |